Photo Credit: X
Richard “Rick” Slayman, the first recipient of a genetically modified pig kidney transplant, has tragically passed away nearly two months after undergoing the groundbreaking procedure. The news of his death has raised questions about the future of xenotransplantation.
In March, at the age of 62, Rick Slayman received a genetically modified pig kidney at Massachusetts General Hospital. Surgeons believed that this innovative approach could provide a solution for patients like Slayman who desperately needed organ transplants. The hope was that the pig kidney would function for at least two years, offering a lifeline to those on the waiting list.
Slayman’s journey began in 2018 when he received a human kidney transplant. Unfortunately, that kidney eventually showed signs of failure, he had to return to dialysis and later on the doctors suggested a pig kidney transplant.
Slayman’s family expressed gratitude to the medical team, acknowledging, "Our family is deeply saddened about the sudden passing of our beloved Rick but take great comfort knowing he inspired so many. Millions of people worldwide have come to know Rick's story. We felt and still feel comforted by the optimism he provided patients desperately waiting for a transplant.
We are extremely grateful to his care team across Massachusetts General Hospital and Mass General Brigham, especially Dr. Williams, Dr. Kawai, and Dr. Riella, who truly did everything they could to help give Rick a second chance. Their enormous efforts leading the xenotransplant gave our family seven more weeks with Rick, and our memories made during that time will remain in our minds and hearts."
Slayman’s case was a testament to the potential of xenotransplantation, offering hope to the thousands of people waiting for life-saving transplants. "The Mass General transplant team is deeply saddened at the sudden passing of Mr. Rick Slayman. We have no indication that it was the result of his recent transplant. Mr. Slayman will forever be seen as a beacon of hope to countless transplant patients worldwide and we are deeply grateful for his trust and willingness to advance the field of xenotransplantation.
We offer our heartfelt condolences to Mr. Slayman's family and loved ones as they remember an extraordinary person whose generosity and kindness touched all who knew him," Massachusetts General Hospital said in a statement.
Slayman’s courage and optimism during this experimental procedure serve as a beacon for others. His family emphasized that Rick’s legacy would endure forever, inspiring hope for those in need of transplants. "Rick accomplished that goal and his hope and optimism will endure forever. His legacy will be one that inspires patients, researchers and health care professionals everywhere," said the family.
